Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
April 09, 2024 16:05 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina” or the “Company”), a biopharmaceutical company dedicated to improving the lives...
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
April 01, 2024 07:15 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina Therapeutics” or the “Company”), a biopharmaceutical company dedicated to...
Rakovina Therapeutics Announces Strategic Pivot to AI
March 27, 2024 16:05 ET
|
Rakovina Therapeutics Inc
Rakovina Therapeutics announces Artificial Intelligence (AI) collaboration
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update
November 27, 2023 19:43 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board
November 27, 2023 09:00 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage...
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
November 20, 2023 09:13 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company focused on the development of novel DNA-damage...
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
August 29, 2023 08:00 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...
Rakovina Therapeutics Announces Results from 2023 Annual General Meeting
June 28, 2023 22:55 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based...
Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update
May 31, 2023 09:05 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients...
Rakovina Therapeutics Inc. Announces Closing of $1.5 Million Convertible Debenture Financing
May 29, 2023 20:57 ET
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) is pleased to announce that it has closed its previously announced...